Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. (BOLT) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
About this filing
Bolt Biotherapeutics, Inc. (BOLT) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Nov 12, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More BOLT filings
- 8-K
Filed Nov 12, 2026
- 4
Filed Nov 10, 2026
- 3
Filed Nov 6, 2026
- SC 13G
Filed Nov 6, 2026
- 4
Filed Oct 27, 2026
- 3
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.